Centrient Pharmaceuticals

Centrient Pharmaceuticals is a global leader in the sustainable manufacturing of essential generic medicines, including antibiotics, statins, and anti-fungals. With a history dating back to 1869 and operations across four continents, the company has evolved from a traditional manufacturer into an innovation partner, emphasizing quality, supply security, and a minimal environmental footprint. It positions itself at the intersection of public health necessity and environmental stewardship, aiming to build a resilient supply chain for foundational therapies while tackling challenges like antimicrobial resistance (AMR).

Sustainable manufacturing platform for generic active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs), utilizing chemical synthesis and developing biotechnology (fermentation) capabilities. Focus on process innovation to reduce environmental footprint, ensure quality, and secure supply. Branded offering includes PureActives®.

Centrient competes in the global generic API market against large Asian manufacturers (notably in India and China) on cost and scale, and against other Western API producers on quality and reliability. Its key differentiation is its strong, branded commitment to sustainable manufacturing and supply chain security, which positions it uniquely for customers and regions prioritizing these factors.